Arlene Morris
CIK 1362520 · CEO · last filed 2026-08-31
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
AFFY price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
4001 MIRANDA AVE.
PALO ALTO, CA 94304
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| COGT | Director | 45,510 | $32.01 | $1.46M | -$1.69M | 7 | 2026-08-31 |
| PTN | Director | 41,580 | $4.77 | $198.3K | $28.7K | 17 | 2026-08-05 |
| VRDN | Director | — | $24.09 | — | $0 | 7 | 2026-07-02 |
| EWTX | Director | — | $39.53 | — | $0 | 4 | 2026-06-17 |
| VIVEVE MEDICAL, INC. (VIVE) Delisted | Director | 2 | $0.00 | $0 | $0 | 13 | 2023-01-05 |
| Cogent Biosciences, Inc. (UMRX) Delisted | Director | — | — | — | $0 | 2 | 2020-06-11 |
| Viridian Therapeutics, Inc.\DE (MGEN) Delisted | Director | — | — | — | $0 | 3 | 2020-05-22 |
| Dimension Therapeutics, Inc. (DMTX) Delisted | Director | — | — | — | $0 | 3 | 2017-11-07 |
| VIVEVE MEDICAL, INC. (TCON) Delisted | Director | — | $0.03 | — | $0 | 1 | 2016-05-20 |
| ALBIREO PHARMA, INC. (BIOD) Delisted | Director | — | — | — | $0 | 2 | 2016-03-08 |
| MNOV | Director | 1,000 | $1.41 | $1.4K | -$28.9K | 7 | 2013-05-23 |
| AFFYMAX INC (AFFY) Delisted | CEO | 75,000 | — | — | -$16.32M | 18 | 2010-09-24 |
Recent Filings · Page 9 of 9
85 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2007-09-11 | AFFYMAX INC (AFFY) Delisted | Mixed | +9,565 | -$5.51M | EDGAR |
| 2007-09-10 | AFFYMAX INC (AFFY) Delisted | Mixed | −26 | -$606.5K | EDGAR |
| 2007-09-05 | AFFYMAX INC (AFFY) Delisted | Sell (S) | −14,683 | -$367.1K | EDGAR |
| 2007-04-03 | MNOV | Grant (A) | — | $0 | EDGAR |
| 2007-01-08 | AFFYMAX INC (AFFY) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.